MedPath

Effects of nalmefen on alcohol consumption in patients with alcoholic liver injury and alcohol-dependent patients

Not Applicable
Recruiting
Conditions
alcoholic liver injury
Registration Number
JPRN-UMIN000048050
Lead Sponsor
ara medical university Hospital Department of Gastroenterology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

1. patients under 19 years old and over 80 years old 2. patients with physical withdrawal symptoms 3. Patients with cancer 4. Pregnant and lactating patients 5. patients using opioids other than nalmefene 6. Patients with severely impaired renal function (eGFR<30 ml/min/1.73m2) 7. Patients who have indicated their refusal to participate in the study 8. dementia (PS2 or higher) 9. patients with psychosis other than alcohol use dependence, who are regularly attending or being hospitalized by a neuropsychiatrist, and who are considered to be difficult to participate in the study 10. other patients who are judged to be ineligible by the investigators and subinvestigators of this study 11. Patients with other addictions 12. patients with intellectual disabilities 13. patients with cerebral organic mental disorder 14. patients with a history of taking Nalmefene (Nalmefene reinstatement) 15. patients with a history of treatment for alcohol dependence at a medical institution specializing in addiction 16. patients with psychiatric disorders other than alcohol dependence

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
iver reserve capacity at each time point.
Secondary Outcome Measures
NameTimeMethod
Various blood biochemical indices related to liver injury (continuous variables)
© Copyright 2025. All Rights Reserved by MedPath